Barry Mathew Berger MD
Cytopathology, Anatomic Pathology, Clinical Pathology
Chief Medical Officer, Naveris Inc
Join to view full profile
40 Cedar RdChestnut Hill, MA 02467
Phone+1 617-293-7738
Dr. Berger is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Barry M. Berger, MD FCAP, is a pathologist based in Newton, MA, with subspecialties in cytopathology, anatomic pathology, and clinical pathology. He completed his medical education at the Perelman School of Medicine with a post Doctoral Fellowship with Dr. Peter Nowell at the University of Pennsylvania in 1976 and pursued further training at Boston University Medical Center (IM) and Brigham and Women's Hospital. (Patholgy, Chief Resident 1981-2) Dr. Berger is currently the Chief Medical Officer at Naveris Inc, and founder of ExPath LLC, while also serving as a Visiting Senior Pathologist at Brigham and Women's Hospital. Previously, he was part of the founding team and the Chief Medical Officer at Exact Sciences Corp and Chair, Pathology and Laboratory Medicine at Harvard Vanguard Medical Associates. He has authored multiple publications on colorectal cancer screening and detection, and holds awards including the Diamond Award and Peer Recognition Award from Harvard Pilgrim HealthCare.
Education & Training
Mass General Brigham/Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1979 - 1982
Boston University Medical CenterInternship, Internal Medicine, 1976 - 1977
Penn MedicinePost-Doctoral Fellowship, 1976 - 1977
Perelman School of Medicine at the University of PennsylvaniaClass of 1976
Certifications & Licensure
MA State Medical License 1982 - 2027
WI State Medical License 2014 - 2021
American Board of Pathology Anatomic Pathology & Clinical Pathology- American Board of Pathology Cytopathology
Awards, Honors, & Recognition
- Diamond Award Harvard Pilgrim Healthcare, 1995
- Peer Recognition Award Harvard Pilgrim HealthCare, 1993
Publications & Presentations
PubMed
- 41 citationsNegative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance.Glenn J Hanna, Scott A Roof, Jamie Jabalee, Eleni M Rettig, Rocco Ferrandino
Clinical Cancer Research. 2023-10-13 - 5 citationsThree-Year Interval for the Multi-Target Stool DNA Test for Colorectal Cancer Screening: A Longitudinal Study.Thomas F Imperiale, Philip T Lavin, Tara N Marti, Debbie Jakubowski, Steven H Itzkowitz
Cancer Prevention Research. 2023-02-06 - 78 citationsDetection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal Carcinoma.Barry M Berger, Glenn J Hanna, Marshall R Posner, Eric M Genden, Julio Lautersztain
Clinical Cancer Research. 2022-10-03
Journal Articles
- Multitarget Stool DNA Testing for Colorectal-Cancer Screening,Imperiale TF, Ransohoff, Itzkowitz DF, Levin TR, Lavin P Lidgard GP, Ahlquist DA, Berger BM, N Engl J Med, 4/3/2014
Press Mentions
Naveris Announces Expanded Medicare Coverage for the NavDx® Test in Identification of Molecular Residual Disease of Anal Squamous Cell CarcinomaNovember 17th, 2025- Naveris Introduces Advanced NavDx+Gyn™ Test for Early Detection of HPV-Driven Gynecologic CancersMarch 27th, 2025
- Naveris to Showcase Advances in Precision Surveillance for HPV-Associated Oropharyngeal Cancer Using the NavDx® Test at the 2024 ASTRO Annual MeetingSeptember 28th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
